Association of Lipopolysaccharide-Binding Protein and Coronary Artery Disease in Men
Philipp M. Lepper, MD*, ,*,
Christian Schumann, MD,
Kathy Triantafilou, PhD ,
F. Maximilian Rasche, MD,
Tibor Schuster, MS ,
Hedwig Frank,
E. Marion Schneider, PhD||,
Martha Triantafilou, PhD and
Maximilian von Eynatten, MD#
* Department of Intensive Care Medicine, University Hospital of Bern (Inselspital), Bern, Switzerland
Department of Internal Medicine II, University of Ulm, Ulm, Germany
Infection and Immunity Group, University of Sussex, Brighton, United Kingdom
Institute of Medical Statistics and Epidemiology, Technical University of Munich, Munich, Germany
|| Section of Experimental Anaesthesiology, University of Ulm, Ulm, Germany
# Department of Nephrology, Technical University of Munich, Munich, Germany.
View larger version (16K):
[in this window]
[in a new window]
[Download PPT slide]
|
Figure 1 Comparison of Serum LBP Levels
Patients with and without incident coronary artery disease (CAD) and control subjects with fibromyalgia and sepsis. Data are presented as individual values, and the central line in each column represents the median. p values by Mann-Whitney U test. LBP = lipopolysaccharide-binding protein.
|
|
View larger version (9K):
[in this window]
[in a new window]
[Download PPT slide]
|
Figure 2 Odds Ratio for CAD
The second, third, and fourth quartiles compared with the first quartile of lipopolysaccharide-binding protein, adjusted for age and body mass index. Vertical bars indicate 95% confidence intervals. CAD = coronary artery disease.
|
|
|
